WebHypertrophic Cardiomyopathy 1. Clinical Characteristics 1.1 Definition and prevalence Hypertrophic cardiomyopathy (HCM) is a primary cardiac disorder characterised by hypertrophy, usually of the left ventricle, in the absence of other loading conditions, such … WebJun 28, 2024 · cardiomyopathy, which is a condition that affects the heart muscle over time; severe lung disease; These same conditions can also cause chronic heart failure.
RACGP - Current challenges facing the athlete and their …
WebIn these models, the progression from acute injury to dilated cardiomyopathy may be simplified into a three-stage process: 6. Phase 1: cardiac injury and activation of the innate immune response. Phase 2: acute myocarditis involving components of the innate and … WebCardiomyopathy is a disease that causes the heart muscle to become weak and ineffective, reducing the heart’s ability to pump blood through the body and possibly leading to heart failure.1 The rate at which cardiomyopathy was recorded by general practitioner (GP) … introas
RACGP - Imaging for cardiac disease: a practical guide for …
HCM is a heterogeneous condition with a genetic basis. However, affected patients within the same family who are known to possess an identical pathogenic mutation can exhibit marked phenotypic variation. Inheritance is generally autosomal dominant with variable penetrance,4,5 and up to 90% of pathogenic HCM … See more Adolescents with HCM are often asymptomatic. The most common symptom – exertional dyspnoea – results from a combination of LVOT obstruction, mitral valve regurgitation, ventricular diastolic dysfunction … See more A comprehensive assessment of an adolescent with suspected HCM requires confirming the diagnosis of HCM and assessing the severity … See more SW is 16 years of age and has non-obstructive HCM. His mother was diagnosed with the condition and subsequently underwent genetic testing, which showed that she had a pathogenic HCM mutation … See more Management of HCM in adolescents may consist of lifestyle modification, pharmacotherapy, septal reduction therapy, ICD insertion … See more WebMar 24, 2024 · Clinical findings suggestive of EGPA include asthma, upper airway/ear disease, rash or subcutaneous nodules, cardiomyopathy, pericarditis, mononeuritis multiplex, or unexplained renal disease, as described in detail separately. (See "Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)".) WebRACGP - gplearning new mlm opportunity